Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$21.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources Display this book on your site! Related Titles The Children's Vaccine Initiative:Achieving the Vision Priorities for the National Vaccine Plan Other Related Titles Vaccine Supply and Innovation (1985) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix A: Product License Holders." Vaccine Supply and Innovation. Washington, DC: The National Academies Press, 1985. Please select a format: Page 161   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore Page 161 Front Matter (R1-R12) 1 Summary (1-13) 2 Vaccines: Past, Present, and Future (14-26) 3 Vaccine Availability: Concerns, Barriers, and Impediments (27-44) 4 Economic Aspects of Vaccine Innovation and Manufacturing (45-64) 5 Vaccine Injury (65-84) 6 Liability for the Production and Sale of Vaccines (85-122) 7 An Approach to Problems of Communication, Coordination, and Collaboration in Vaccine Policy (123-135) 8 Vaccine Injury Compensation and Liability Remedies (136-160) Appendix A: Product License Holders (161-163) Appendix B: A Vaccine Supply Public Insurance Option (164-165) Appendix C: No-Fault Vaccine Injury Insurance (166-170) Appendix D: Injury Compensation Systems in the United States (171-175) Appendix E: Vaccine-Injury Compensation in Other Countries (176-182) Appendix F: Proposed Vaccine-Injury Compensation Systems (183-191) Appendix G: Mechanisms Used in Other Countries to Ensure Vaccine Supply (192-193) Appendix H: Background Papers (194-195) Appendix I: Biographical Notes on Committee Members and Consultants (196-200) Appendix J: Recommendations for the Proposed Vaccine Commission (201-202) Index (203-210)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 161
Appendix A PRODUCT LICENSE HOLDERS Adenovirus Vaccine, Live, Oral, Type 4 Wyeth Laboratories, Inc. Adenovirus Vaccine, Live, Oral, Type 7 Wyeth Laboratories, Inc. Anthrax Vaccine Adsorbed Michigan Department of Public Health BCG Vaccine Connaught Laboratories Ltd. Glaxo Operations U.K. Ltd. University of Illinois Cholera Vaccine Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Merck Sharp & Dohme Wyeth Laboratories, Inc. Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed Connaught Laboratories, Inc. Eli Lilly and Company Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Massachusetts Public Health Biologic Laboratories Merck Sharp & Dohme Michigan Department of Public Health Wyeth Laboratories, Inc. Diphtheria and Tetanus Toxoids Adsorbed Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Massachusetts Public Health Biologic Laboratories Michigan Department of Public Health Wyeth Laboratories, Inc. Diphtheria Toxoid Connaught Laboratories, Inc. Istituto Sieroterapico Vaccinogeno Toscano Sclavo Wyeth Laboratories, Inc. Prepared by A. Demers, Division of Product Certification, Food and Drug Administration. 161

OCR for page 162
162 Diphtheria Toxoid Adsorbed Istituto Sieroterapico Vaccinogeno Toscano Sclavo Michigan Department of Public Health Wyeth Laboratories, Inc. Hepatitis B Vaccine Merck Sharp & Dohme Influenza Virus Vaccine Connaught Laboratories, Inc. Lederle Laboratories Merck Sharp & Dohme Parke-Davis Wyeth Laboratories, Inc. Measles Virus Vaccine, Live, Attenuated Merck Sharp & Dohme Measles and Mumps Virus Vaccine, Live Merck Sharp & Dohme Measles and Rubella Virus Vaccine, Live Merck Sharp & Dohme Measles-Smallpox Vaccine, Live Merck Sharp & Dohme Measles, Mumps, and Rubella Virus Vaccine, Live Merck Sharp & Dohme Meningococcal Polysaccharide Vaccine Connaught Laboratories, Inc. Merck Sharp & Dohme Mumps Virus Vaccine, Live Merck Sharp & Dohme Pertussis Vaccine Connaught Laboratories, Inc. Wyeth Laboratories, Inc. Pertussis Vaccine Adsorbed Michigan Department of Public Health Plague Vaccine Miles Laboratories, Inc. Pneumococcal Vaccine, Polyvalent Lederle Laboratories Merck Sharp & Dohme Poliomyelitis Vaccine Connaught Laboratories Ltd. Poliovirus Vaccine, Live, Oral, Trivalent Lederle Laboratories Poliovirus Vaccine, Live, Oral, Type 1 Lederle Laboratories Poliovirus Vaccine, Live, Oral, Type 2 Lederle Laboratories Poliovirus Vaccine, Live, Oral, Type 3 Lederle Laboratories Rabies Vaccine (Human Diploid Cell) Institut Merieux Wyeth Laboratories, Inc.

OCR for page 163
163 Rubella and Mumps Virus Vaccine, Live Merck Sharp & Dohme Rubella Virus Vaccine, Live Merck Sharp & Dohme Wellcome Foundation Ltd. Smallpox Vaccine Connaught Laboratories, Inc.` Michigan Department of Public Health Wyeth Laboratories, Inc. Tetanus and Diphtheria Toxoids Adsorbed (for adult use) Connaught Laboratories, Tnc Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Massachusetts Public Health Biologic Laboratories Merck Sharp & Dohme Wyeth Laboratories, Inc. Tetanus Toxoid Connaught Laboratories, Inc Connaught Laboratories Ltd. Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Massachusetts Public Health Biologic Laboratories Merck Sharp & Dohme Wyeth Laboratories, Inc. Tetanus Toxoid Adsorbed Connaught Laboratories, Inc. Istituto Sieroterapico Vaccinogeno Toscano Sclavo Lederle Laboratories Massachusetts Public Health Biologic Laboratories Merck Sharp & Dohme Michigan Department of Public Health Swiss Serum and Vaccine Institute Berne Wyeth Laboratories, Inc. Typhoid Vaccine Massachusetts Public Health Biologic Laboratories Merck Sharp & Dohme Michigan Department of Public Health Wyeth Laboratories, Inc. Yellow Fever Vaccine Connaught Laboratories, Inc. . .

Representative terms from entire chapter:

lederle laboratories